drospirenone
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
9 FDA-registered drug labelers
Bayer HealthCare Pharmaceuticals Inc.
Hubei Gedian Humanwell Pharmaceutical Co., Ltd
Industriale Chimica s.r.l.
NEWCHEM SPA
Quimica Sintetica S.A.
Sicor S.r.l.
Sterling Chemical Malta Ltd
STERLING SPA
SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Angeliq
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Drospirenone; Ethinyl Estradiol Tablet
05/02/2025to be discontinued
Drospirenone; Ethinyl Estradiol Tablet
06/13/2025Chemical Identity
CAS67392-87-4
PubChem CID68873
DTXSIDDTXSID7046465
FormulaC24H30O3
Mol. Weight366.5 g/mol
SMILESCC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
Data Sources
688732026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/drospirenone/cids/JSON
Archive: data/sources/pubchem_name/drospirenone.json
CAS 67392-87-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 67392-87-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json